Clinical Trials

ANZCHOG is the national Cancer Cooperative Trials Group (CCTG) for childhood and adolescent cancers in Australia and New Zealand.

As the CCTG, ANZCHOG is responsible for sponsorship of national clinical trials. To do this, we partner with a range of government, philanthropic and charity groups to develop new trials and bring more international trials to Australia and New Zealand.

This page provides information on clinical trials that are sponsored by ANZCHOG. 

A full list of trials available for children and adolescents with cancer, and where they are open, can be found on the ANZCHOG Children’s Cancer Clinical Trials Repository (ACCCTR). The ACCCTR includes trials sponsored by ANZCHOG as well as other Sponsors.

Trial eligibility is extensive and often varies depending on medical history and current health status. Your child’s oncologist and medical team are the best people to talk to about trial eligibility. They will be able to provide personalised advice based on your individual circumstances.

Filter by

Trial Stage
  • Trial Stage
  • Closed to Recruitment
  • In Development
  • Open
  • Preparing to Open
Location
  • Location
  • New Zealand
  • NSW
  • QLD
  • SA
  • TAS
  • VIC
  • WA
Disease Type
  • Disease Type
  • Bone Cancers (Ewing Sarcoma/Osteosarcoma)
  • Brain and other Central Nervous System (CNS) Tumours
  • Germ Cell Tumours
  • Hodgkin Lymphoma
  • Kidney (Renal) Tumours
  • Leukaemia
  • Liver tumours
  • Neuroblastoma
  • Non-Hodgkin Lymphoma
  • Other
  • Soft Tissue Sarcomas
Disease Stage
  • Disease Stage
  • Newly diagnosed
  • Other
  • Relapsed/Recurrent

SJiMB21

Brain and other Central Nervous System (CNS) Tumours
Status: In Development

Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children with Newly Diagnosed Medulloblastoma

Newly diagnosed
Read more

RAVEN

Leukaemia

A phase I/II trial treating relapsed acute lymphoblastic leukemia with venetoclax and navitoclax

Relapsed/Recurrent
Read more

CONNECT1905

Brain and other Central Nervous System (CNS) Tumours
Status: Open | NSW, QLD, WA

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Pediatric Adamantinomatous Craniopharyngioma

Relapsed/Recurrent
Read more

MetMED

Brain and other Central Nervous System (CNS) Tumours
Status: Open | NSW, VIC, WA

Phase III randomized double-blind placebo-controlled trial of metformin for white matter repair and cognitive recovery in paediatric brain tumour patients

Other
Read more

PNOC-022 (DMG-ACT)

Brain and other Central Nervous System (CNS) Tumours
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas including Diffuse Intrinsic Pontine Gliomas at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression.

Newly diagnosed, Relapsed/Recurrent
Read more

INTER-EWING-1

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Soft Tissue Sarcomas
Status: Open | VIC, WA

INTERnational scientific program in clinical research to improve outcomes of newly diagnosed EWING sarcoma

Newly diagnosed
Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168